117 related articles for article (PubMed ID: 9349536)
21. Sequential changes of [H]forskolin, [H]cyclohexyladenosine and [H]PN200-110 binding sites in the brain of 6-hydroxydopamine-lesioned rats.
Araki T; Tanji H; Kato H; Imai Y; Mizugaki M; Itoyama Y
Acta Physiol Scand; 2000 May; 169(1):71-8. PubMed ID: 10759613
[TBL] [Abstract][Full Text] [Related]
22. Dopamine receptor-modulated [35S]GTPgammaS binding in striatum of 6-hydroxydopamine-lesioned rats.
Geurts M; Hermans E; Cumps J; Maloteaux JM
Brain Res; 1999 Sep; 841(1-2):135-42. PubMed ID: 10546996
[TBL] [Abstract][Full Text] [Related]
23. Differential requirements of sodium for coupling of cannabinoid receptors to adenylyl cyclase in rat brain membranes.
Pacheco MA; Ward SJ; Childers SR
J Neurochem; 1994 May; 62(5):1773-82. PubMed ID: 8158127
[TBL] [Abstract][Full Text] [Related]
24. Levels of stimulatory G protein are increased in the rat striatum after neonatal lesion of dopamine neurons.
Penit-Soria J; Durand C; Besson MJ; Herve D
Neuroreport; 1997 Mar; 8(4):829-33. PubMed ID: 9141047
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological inhibition of forskolin-stimulated adenylate cyclase activity in rat brain by melatonin, its analogs, and diazepam.
Niles LP; Hashemi FS
Biochem Pharmacol; 1990 Dec; 40(12):2701-5. PubMed ID: 2260993
[TBL] [Abstract][Full Text] [Related]
26. Diabetes abolishes the GTP-dependent, but not the receptor-dependent inhibitory function of the inhibitory guanine-nucleotide-binding regulatory protein (Gi) on adipocyte adenylate cyclase activity.
Strassheim D; Milligan G; Houslay MD
Biochem J; 1990 Mar; 266(2):521-6. PubMed ID: 2156498
[TBL] [Abstract][Full Text] [Related]
27. Adenylyl cyclase activity in Alzheimer's disease brain: stimulatory and inhibitory signal transduction pathways are differently affected.
Schnecko A; Witte K; Bohl J; Ohm T; Lemmer B
Brain Res; 1994 May; 644(2):291-6. PubMed ID: 7914148
[TBL] [Abstract][Full Text] [Related]
28. Stimulation of adenylate cyclase activity by benzazepine D-1 dopamine agonists with varying efficacies in the 6-hydroxydopamine lesioned rat--relationship to circling behaviour.
Gnanalingham KK; Hunter AJ; Jenner P; Marsden CD
Biochem Pharmacol; 1995 May; 49(9):1185-93. PubMed ID: 7763300
[TBL] [Abstract][Full Text] [Related]
29. Analysis of the adenylate cyclase signalling system, and alterations induced by culture with insulin, in a novel SV40-DNA-immortalized hepatocyte cell line (P9 cells).
Livingstone C; MacDonald C; Willett B; Houslay MD
Biochem J; 1994 Jun; 300 ( Pt 3)(Pt 3):835-42. PubMed ID: 8010967
[TBL] [Abstract][Full Text] [Related]
30. Modification of G protein-coupled functions by low-pH pretreatment of membranes from NG108-15 cells: increase in opioid agonist efficacy by decreased inactivation of G proteins.
Selley DE; Breivogel CS; Childers SR
Mol Pharmacol; 1993 Oct; 44(4):731-41. PubMed ID: 8232223
[TBL] [Abstract][Full Text] [Related]
31. BW373U86: a nonpeptidic delta-opioid agonist with novel receptor-G protein-mediated actions in rat brain membranes and neuroblastoma cells.
Childers SR; Fleming LM; Selley DE; McNutt RW; Chang KJ
Mol Pharmacol; 1993 Oct; 44(4):827-34. PubMed ID: 8232233
[TBL] [Abstract][Full Text] [Related]
32. Ethanol-induced modification of somatostatin-responsive adenylyl cyclase in rat exocrine pancreas.
Alvaro-Alonso I; Boyano-Adánez MC; Arilla E
Biochim Biophys Acta; 1995 Jul; 1268(1):115-21. PubMed ID: 7626657
[TBL] [Abstract][Full Text] [Related]
33. GTP regulation of (-)-stepholidine binding to R(H) of D1 dopamine receptors in calf striatum.
Dong ZJ; Chen LJ; Jin GZ; Creese I
Biochem Pharmacol; 1997 Jul; 54(2):227-32. PubMed ID: 9271326
[TBL] [Abstract][Full Text] [Related]
34. Sequential changes of cholinergic and dopaminergic receptors in brains after 6-hydroxydopamine lesions of the medial forebrain bundle in rats.
Araki T; Tanji H; Fujihara K; Kato H; Imai Y; Mizugaki M; Itoyama Y
J Neural Transm (Vienna); 2000; 107(8-9):873-84. PubMed ID: 11041269
[TBL] [Abstract][Full Text] [Related]
35. The antidopaminergic action of S-20098 is mediated by benzodiazepine/GABA(A) receptors in the striatum.
Tenn CC; Niles LP
Brain Res; 1997 May; 756(1-2):293-6. PubMed ID: 9187346
[TBL] [Abstract][Full Text] [Related]
36. Involvement of the beta gamma subunits of inhibitory GTP-binding protein in chemoattractant receptor-mediated potentiation of cyclic AMP formation in guinea pig neutrophils.
Suzuki T; Hazeki O; Hazeki K; Ui M; Katada T
Biochim Biophys Acta; 1996 Aug; 1313(1):72-8. PubMed ID: 8781552
[TBL] [Abstract][Full Text] [Related]
37. 5-HT-stimulated [35S]guanosine-5'-O-(3-thio)triphosphate binding as an assay for functional activation of G proteins coupled with 5-HT1B receptors in rat striatal membranes.
Odagaki Y; Toyoshima R
Naunyn Schmiedebergs Arch Pharmacol; 2006 Feb; 372(5):335-45. PubMed ID: 16491386
[TBL] [Abstract][Full Text] [Related]
38. Opioid-inhibited adenylyl cyclase in rat brain membranes: lack of correlation with high-affinity opioid receptor binding sites.
Nijssen PC; Sexton T; Childers SR
J Neurochem; 1992 Dec; 59(6):2251-62. PubMed ID: 1331327
[TBL] [Abstract][Full Text] [Related]
39. Adaptive changes in the number of Gs- and Gi-proteins underlie adenylyl cyclase sensitization in morphine-treated rat striatal neurons.
Van Vliet BJ; Van Rijswijk AL; Wardeh G; Mulder AH; Schoffelmeer AN
Eur J Pharmacol; 1993 Mar; 245(1):23-9. PubMed ID: 8386668
[TBL] [Abstract][Full Text] [Related]
40. Desensitization of adenosine A2 receptors in the striatum of the rat following chronic treatment with diazepam.
Hawkins M; Pan W; Stefanovich P; Radulovacki M
Neuropharmacology; 1988 Nov; 27(11):1131-40. PubMed ID: 2849727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
